Cencora, Inc. $COR Shares Bought by Handelsbanken Fonder AB

Handelsbanken Fonder AB raised its position in Cencora, Inc. (NYSE:COR) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 347,293 shares of the company’s stock after acquiring an additional 7,461 shares during the quarter. Handelsbanken Fonder AB’s holdings in Cencora were worth $117,298,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Cencora by 13.0% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 48,270 shares of the company’s stock valued at $15,086,000 after buying an additional 5,543 shares during the period. AustralianSuper Pty Ltd purchased a new position in shares of Cencora in the 3rd quarter valued at about $26,191,000. Mediolanum International Funds Ltd boosted its stake in shares of Cencora by 133.0% in the 3rd quarter. Mediolanum International Funds Ltd now owns 56,293 shares of the company’s stock valued at $17,342,000 after buying an additional 32,138 shares during the period. Chilton Investment Co. Inc. purchased a new position in shares of Cencora in the 3rd quarter valued at about $459,000. Finally, Advisors Asset Management Inc. boosted its stake in shares of Cencora by 40.3% in the 3rd quarter. Advisors Asset Management Inc. now owns 17,302 shares of the company’s stock valued at $5,407,000 after buying an additional 4,973 shares during the period. 97.52% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

COR has been the subject of several recent research reports. Leerink Partners reiterated an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cencora in a research note on Monday, May 4th. Evercore set a $360.00 price objective on Cencora in a research note on Wednesday, April 8th. JPMorgan Chase & Co. lifted their price objective on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Finally, Robert W. Baird decreased their price objective on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday, May 7th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $380.25.

Cencora Price Performance

COR stock opened at $262.15 on Tuesday. The business has a 50 day moving average price of $312.71 and a 200 day moving average price of $338.72. The stock has a market cap of $51.00 billion, a price-to-earnings ratio of 20.10, a PEG ratio of 1.19 and a beta of 0.64. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). The business had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.Cencora’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Equities research analysts anticipate that Cencora, Inc. will post 17.76 earnings per share for the current fiscal year.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be paid a dividend of $0.60 per share. The ex-dividend date is Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.9%. Cencora’s payout ratio is presently 18.40%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.